SCIEX, a Danaher organization and leader in life science analytical technologies, announced novel services intended to support clinical laboratories in shifting from sample to answer rapidly with greater confidence, control, and productivity. Presented at ADLM, the ExionLC MD technology and SCIEX OS software for the clinical portfolio streamline complex workflows, automate routine technology, and help deliver high-quality patient-critical outcomes.
The ExionLC MD technology delivers high-performance UHPLC separation with the strength and reproducibility required for medical care workflows, empowering labs to generate consistent, high-quality information with confidence. Intended to work with the Citrine system and the SCIEX 4500MD system, it provides complete LC-MS/MS services for healthcare labs. Significant features include:
"Clinical labs are under increasing pressure to deliver reliable results faster, while managing growing workflow complexity, staffing challenges, and evolving regulatory expectations," explains Chris Hagen, President of SCIEX. "Clinical diagnostics is a strategic priority for SCIEX. We continue to invest in technology, workflows, and partnerships that help clinical labs succeed. The ExionLC MD system and SCIEX OS software are our latest steps in supporting customers with solutions that simplify operations, improve productivity, and expand access to high-quality mass spectrometry testing."
According to Towards Healthcare, the life science quality management software market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 3.09 billion in 2026 to approximately USD 9.14 billion by 2035, representing a compound annual growth rate (CAGR) of 12.8% from 2026 to 2035, driven by improved quality management technology provides a diverse and dynamic toolkit to renovate processes, growing effectiveness, reduces the expenses of manufacturing, and ensure adherence to the advance standards set by government bodies. It supports ensuring product safety, effectiveness, quality, and regulatory compliance in these regulated organizations. Quality management in life sciences is significant for confirming product safety, consistency, and regulatory compliance in the highly regulated sectors like pharmaceuticals, biotechnology, and medical tools. By reducing errors and variability in manufacturing, quality management plays a significant role in maintaining patient safety and public well-being.
SCIEX, a Danaher organization and leader in life science analytical technologies, empowers consumers to solve the most impactful analytical trials in characterization and quantitation. With revolutionary innovation and outstanding support and reliability, SCIEX has been at the front of the field for over 50 years. ​Since the launch of the first-ever commercially successful triple quadrupole in 1981, this company continues to develop technologies and services that influence life-changing research and results. Therefore, thousands of life science experts around the world choose SCIEX to get the answers they can trust.
Danaher is a foremost worldwide life sciences and diagnostics innovator, committed to hastening the power of science and technology to enhance human health. Through a connected ecosystem of industry-leading businesses, work side by side with consumers to solve their most complex scientific and clinical challenges, supporting shift innovations from discovery to delivery rapidly for patients who rely on them. Powered by the Danaher Business Technology, advanced science and technology, and proven capability to innovate, support allows faster, more precise diagnoses and reduces the time, expenses, and risk needed to discover, advance, and deliver life-changing therapies. Through continuous improvement and operational excellence, around 60,000 associates globally are focused on delivering lasting impact and enhancing quality of life globally, while building a healthier, more sustainable future.
A recent report by Towards Healthcare highlights that the life science quality management software market is growing, as it allows life-science production industries to meet the novel demands of quality management and helps innovation in precision medicine. The transformation toward cloud-driven eQMS platforms supports remote audits and worldwide partnerships, lessening operational bottlenecks and accelerating decision-making across geographies. Well-organized and streamlined operations are significant for pharmaceutical organizations to meet market demands, keep competitiveness, and enhance resource utilization. An eQMS software offers a framework for procedure optimization, removing inefficiencies and lowering waste.
